InMode FaceTite/AccuTite
Bipolar/Multipolar RF Tightening · Minimally invasive RFAL
The InMode FaceTite/AccuTite typically sells new in the $100k–$160k range in the US, with used and refurbished systems around $50k–$90k. InMode FaceTite/AccuTite holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.
What it's actually cleared for: Cleared as InMode RF System parts — electrocoagulation and hemostasis in dermatologic/general surgery
Last verified: August 6, 2026 · How we verify
New: $100k–$160k|Used: $50k–$90kmarket estimate, no email required
| Manufacturer | InMode |
|---|---|
| Company | Owner: Publicly traded (NASDAQ: INMD; no single controlling owner) (public company, since 2019) · Distribution: direct |
| Category | RF Microneedling, Tightening & HIFU |
| Technology | Minimally invasive RFAL |
| FDA status | FDA Cleared |
| New price range | $100k–$160k |
| Used price range | $50k–$90k |
| Consumables | Not published |
| Launch year | 2018 |
| Last verified | August 6, 2026 |
Overview
Subdermal cannula RF for jowls/neck; pairs with Morpheus8
FDA & regulatory status
What it's actually cleared for:
Cleared as InMode RF System parts — electrocoagulation and hemostasis in dermatologic/general surgery
510(k) numbers
K171593; K182325; K240780
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
Economics data for this platform hasn't been published yet.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 5, 2026
FDA status
Unknown → Cleared
Source: Automatic record update
August 5, 2026
FDA K-numbers
K171593; K182325; K240780
Source: Automatic record update
August 5, 2026
FDA indication
Cleared as InMode RF System parts — electrocoagulation and hemostasis in dermatologic/general surgery
Source: Automatic record update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.